The inhibition of rat liver nuclear ribonucleic acid synthesis by galactosamine and its reversal by uridine.
D000225:Adenine / Q000494:pharmacology; D000818:Animals; D002467:Cell Nucleus / Q000032:analysis / Q000378:metabolism; D002850:Chromatography, Gel; D004247:DNA / Q000032:analysis; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D005260:Female; D005688:Galactosamine / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D009963:Orotic Acid / Q000378:metabolism; D012313:RNA / Q000032:analysis / Q000096:biosynthesis* / Q000378:metabolism; D051381:Rats; D012995:Solubility; D013268:Stimulation, Chemical; D013997:Time Factors; D014316:Tritium; D014500:Uracil Nucleotides / Q000378:metabolism; D014529:Uridine / Q000378:metabolism / Q000494:pharmacology*
D014500:Uracil Nucleotides; D014316:Tritium; D009963:Orotic Acid; D012313:RNA; D005688:Galactosamine; D004247:DNA; D000225:Adenine; D014529:Uridine